706820-96-4

Basic information

• Product Name: 5-Cyano-2-methoxyphenylboronic acid pinacol ester
• Synonyms: 5-Cyano-2-methoxyphenylboronic acid pinacol ester;Benzonitrile, 4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;4-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
• CAS NO: 706820-96-4
• Molecular Formula: C14H18BNO3
• Molecular Weight: 259.11
• Product Categories: Aryl;Organoborons
• Mol File: 706820-96-4.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-Cyano-2-methoxyphenylboronic acid pinacol ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Cyano-2-methoxyphenylboronic acid pinacol ester(706820-96-4)
• EPA Substance Registry System: 5-Cyano-2-methoxyphenylboronic acid pinacol ester(706820-96-4)

Safety Data

• Hazardous Substances Data: 706820-96-4(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
5-Cyano-2-methoxyphenylboronic acid pinacol ester is used as a reagent in Suzuki-Miyaura cross-coupling reactions for the formation of carbon-carbon bonds. This reaction is a powerful tool in organic synthesis, allowing for the creation of a wide range of complex organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 5-Cyano-2-methoxyphenylboronic acid pinacol ester is used as a building block for the development of new drugs. Its ability to form strong and selective interactions with biological targets makes it a promising candidate for the creation of novel therapeutic agents.
Used in Agrochemical Development:
Similarly, in the agrochemical industry, 5-Cyano-2-methoxyphenylboronic acid pinacol ester is utilized as a key component in the synthesis of new agrochemicals. Its potential to interact selectively with biological targets can lead to the development of more effective and targeted pesticides and other agricultural chemicals.
Used in Research Laboratories:
5-Cyano-2-methoxyphenylboronic acid pinacol ester is used as a valuable tool in research laboratories for the synthesis and study of various organic compounds. Its stability and ease of handling make it an ideal choice for researchers working in the field of organic chemistry.

Upstream product

• 874-90-8 4-methoxybenzonitrile 
• 25015-63-8 4,4,5,5-tetramethyl-[1,3,2]-dioxaboralane 
• 117572-79-9 3-bromo-4-methoxybenzonitrile 
• 73183-34-3 bis(pinacol)diborane 
• 2315-86-8 3-bromo-4-hydroxybenzonitrile 

Relevant articles and documents

Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials

The protein kinase PfCLK3 plays a critical role in the regulation of malarial parasite RNA splicing and is essential for the survival of blood stage Plasmodium falciparum. We recently validated PfCLK3 as a drug target in malaria that offers prophylactic,

ALANINE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE

The description relates to inhibitors of Apoptosis Proteins (TAPs) binding compounds, including Afunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the description provides compounds, which contain on one end a ligand which binds to the IAP E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.

SUBSTITUTED PURINONE COMPOUNDS

The invention relates to compounds of formula (I): (I) as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.

Process for producing cyano substituted arene boranes and compounds

A process for producing cyano substituted arene boranes is described. The compounds are useful intermediates to pharmaceutical compounds using the cyano group as a reactant.

Sterically directed functionalization of aromatic C-H bonds: Selective borylation ortho to cyano groups in arenes and heterocycles

Ir-catalyzed borylations of 4-substituted benzonitriles are described. In contrast to electrophilic aromatic substitutions and directed ortho metalations, C-H activation/borylation enables functionalization at the 2-position, adjacent to the cyano group, when the 4-subsitutent is larger than cyano. When an excess of borane reagent is used, diborylation can be achieved with a single regioisomer being formed in certain cases. Extension of sterically directed borylation to cyano-substituted, five- and six-membered ring heterocycles is also reported.

2-(2-HYDROXYBIPHENYL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE DERIVATIVES AS FACTOR VIIA INHIBITORS

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders, cancer or rheumatoid arthritis. Processes for preparing these inhibitors are also disclosed.